![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by AFP Staff Writers Santiago (AFP) Jan 20, 2021
Chile on Wednesday became the latest country to give emergency approval to China's CoronaVac vaccine as it battles the coronavirus epidemic which has claimed more than 17,500 lives in the country to date. CoronaVac was developed by China's Sinovac firm and has been approved for emergency use in Brazil, China, Indonesia and Turkey. Chile joined the small club on Wednesday when its ISP public health institute gave the go-ahead. The country hopes to receive 10 million doses of the vaccine, adding to the Pfizer/Biontech jab that it has already started distributing. ISP director Heriberto Garcia told reporters Wednesday the approval was given after trials showed CoronaVac was safe and 78 percent effective in preventing infection if given in two doses to people aged between 18 and 60. Earlier this month, Brazil said its own tests had shown CoronaVac to be 50 percent effective. Panama rolled out its own vaccination campaign Wednesday with nurse Violeta Gaona receiving the first shot. The country has the highest infection rate in Central America, with some 300,000 cases and more than 4,800 deaths. Some countries have been having trouble laying their hands on enough vaccine doses, and the World Health Organization has said rich countries are hogging most of the doses as it warned of a "catastrophic moral failure" if poor countries are left behind.
![]() ![]() Chinese city rushes to build massive Covid-19 quarantine centre Beijing (AFP) Jan 19, 2021 Thousands of prefabricated rooms fill a vast field on the outskirts of China's Shijiazhuang city as construction crews work around the clock to erect a large quarantine facility to curb the city's growing Covid-19 outbreak. China has largely brought the virus under control even as the rest of the world struggles with mounting deaths and overburdened hospitals. But a spate of small, localised outbreaks has prompted Chinese officials to order mass testing, strict lockdowns and to prepare to move ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |